EUVIMEDEUVIMED entdecken
Crossref

DPP-4i, GLP-1RA and SGLT2i have differing autoimmune disease risks

Reactions Weekly · 18.07.2026 · 2119 (1) · 10-10

DOI: 10.1007/s40278-026-96309-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reactions Weekly, online erschienen am 18.07.2026. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). DPP-4i, GLP-1RA and SGLT2i have differing autoimmune disease risks. Reactions Weekly, 2119(1), 10-10. https://doi.org/10.1007/s40278-026-96309-2

Vancouver

DPP-4i, GLP-1RA and SGLT2i have differing autoimmune disease risks. Reactions Weekly. 2026;2119(1):10-10. doi:10.1007/s40278-026-96309-2

BibTeX
@article{euvimed2026,
  title = {DPP-4i, GLP-1RA and SGLT2i have differing autoimmune disease risks},
  journal = {Reactions Weekly},
  year = {2026},
  volume = {2119},
  number = {1},
  pages = {10--10},
  doi = {10.1007/s40278-026-96309-2}
}
Kostenlos starten →